These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38094385)

  • 1. Retracted: Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9838096. PubMed ID: 38094385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9761231. PubMed ID: 37388089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma.
    Zhang G; Chen R; Zhu L; Ma H; Tang H; Shang C; Wang J; Zhang D; Li Q; Liu J
    Comput Math Methods Med; 2022; 2022():3440586. PubMed ID: 36110575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
    Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
    Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma.
    Xia P; Huang Y; Chen G
    Front Oncol; 2022; 12():940220. PubMed ID: 36033510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang W; Cao W; Tong Z; Jin Q; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Zhou S
    Front Oncol; 2022; 12():1011000. PubMed ID: 36185274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity.
    Liu B; Feng C; Liu Z; Tu C; Li Z
    Front Pharmacol; 2022; 13():944158. PubMed ID: 36105232
    [No Abstract]   [Full Text] [Related]  

  • 8. Retracted: A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9812519. PubMed ID: 38077915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors.
    Li H; Lv Z; Liu M
    Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
    International BR
    Biomed Res Int; 2024; 2024():9854370. PubMed ID: 38550201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [No Abstract]   [Full Text] [Related]  

  • 12. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.
    Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X
    Front Genet; 2022; 13():951239. PubMed ID: 36186436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9849047. PubMed ID: 38124932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
    He Y; Ye Y; Tian W; Qiu H
    Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
    Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
    Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: Identification of Prognostic Fatty Acid Metabolism lncRNAs and Potential Molecular Targeting Drugs in Uveal Melanoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9813652. PubMed ID: 38077905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    International BR
    Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification and Potential Mechanisms of a 7-MicroRNA Signature That Predicts Prognosis in Patients with Lower-Grade Glioma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9807106. PubMed ID: 38094830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma.
    Chen Y; Hu D; Wang F; Huang C; Xie H; Jin L
    Aging (Albany NY); 2023 Nov; 15(21):12296-12313. PubMed ID: 37934582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.